Literature DB >> 27587550

The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis.

Giovanni Sotgiu1, Payam Nahid2, Robert Loddenkemper3, Ibrahim Abubakar4, Marc Miravitlles5, Giovanni Battista Migliori6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27587550     DOI: 10.1183/13993003.01356-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis.

Authors:  Vikram Saini; Nicole C Ammerman; Yong Seok Chang; Rokeya Tasneen; Richard E Chaisson; Sanjay Jain; Eric Nuermberger; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 2.  Intrathecal Antibacterial and Antifungal Therapies.

Authors:  Roland Nau; Claudia Blei; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

3.  Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.

Authors:  Nicole C Ammerman; Rosemary V Swanson; Elaine M Bautista; Deepak V Almeida; Vikram Saini; Till F Omansen; Haidan Guo; Yong Seok Chang; Si-Yang Li; Asa Tapley; Rokeya Tasneen; Sandeep Tyagi; Fabrice Betoudji; Chivonne Moodley; Bongani Ngcobo; Logan Pillay; Linda A Bester; Sanil D Singh; Richard E Chaisson; Eric Nuermberger; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 4.  Treatment of drug-susceptible tuberculosis among people living with human immunodeficiency virus infection: an update.

Authors:  April C Pettit; Bryan E Shepherd; Timothy R Sterling
Journal:  Curr Opin HIV AIDS       Date:  2018-11       Impact factor: 4.283

5.  Predictors of mortality among intensive care unit patients coinfected with tuberculosis and HIV.

Authors:  Marcia Danielle Ferreira; Cynthia Pessoa das Neves; Alexandra Brito de Souza; Francisco Beraldi-Magalhães; Giovanni Battista Migliori; Afrânio Lineu Kritski; Marcelo Cordeiro-Santos
Journal:  J Bras Pneumol       Date:  2018-04       Impact factor: 2.624

6.  TB management in the European Union/European Economic Area: a multi-centre survey.

Authors:  G Sotgiu; S Rosales-Klintz; R Centis; L D'Ambrosio; R Verduin; A M Correia; A Cirule; R Duarte; B Gadzheva; G Gualano; H Kunst; F Palmieri; V Riekstina; D Stefanova; S Tiberi; M J van der Werf; G B Migliori
Journal:  Int J Tuberc Lung Dis       Date:  2021-02-01       Impact factor: 2.373

Review 7.  Tuberculosis treatment.

Authors:  Marcelo Fouad Rabahi; José Laerte Rodrigues da Silva Júnior; Anna Carolina Galvão Ferreira; Daniela Graner Schuwartz Tannus-Silva; Marcus Barreto Conde
Journal:  J Bras Pneumol       Date:  2017 Nov-Dec       Impact factor: 2.624

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.